FDA Drug Application (020757) for AVAPRO by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number020757
Product Number001
FormTABLET;ORAL
Dosage75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAVAPRO
Active IngredientIRBESARTAN

Active IngredientCount
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by SANOFI AVENTIS US